Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
WILMINGTON, Del. and SHANGHAI, China, July 02, 2019 (GLOBE NEWSWIRE) -- Incyte (NASDAQ:INCY) and Zai Lab Ltd. (NASDAQ:ZLAB) today announced that the companies have entered into a collaboration and...
-
SHANGHAI, China and SAN FRANCISCO, June 12, 2019 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB), a Shanghai-based innovative commercial stage biopharmaceutical company, today announced its...
-
- Zai Lab to Lead the Development and Commercialization of Ripretinib in Greater China -- Deciphera To Receive $20 Million Upfront Cash Payment, up to $185 Million in Potential Future Milestones and...
-
SHANGHAI, China and SAN FRANCISCO, June 03, 2019 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB), a China and U.S.-based innovative commercial stage biopharmaceutical company, today announced the...
-
SHANGHAI, China, May 29, 2019 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ:ZLAB), a China and U.S.-based innovative commercial stage biopharmaceutical company, today announced that members of the...
-
Approval allows Zai Lab to enroll patients in a global Phase 3 clinical trial in collaboration with Entasis Therapeutics More than 200,000 cases of A. baumannii infections in China annually -...
-
SHANGHAI, China, May 09, 2019 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ:ZLAB), a China and U.S.-based innovative commercial stage biopharmaceutical company, today announced that members of the...
-
SHANGHAI, China, May 02, 2019 (GLOBE NEWSWIRE) -- Zai Lab Limited (“Zai Lab” or the “Company”) (NASDAQ: ZLAB), a China and U.S.-based innovative commercial stage biopharmaceutical company, today...
-
SHANGHAI, China, May 01, 2019 (GLOBE NEWSWIRE) -- Zai Lab Limited (“Zai Lab” or the “Company”) (NASDAQ:ZLAB), a China and U.S.-based innovative commercial stage biopharmaceutical company, today...
-
SHANGHAI, China, April 17, 2019 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB), a China and U.S.-based innovative commercial stage biopharmaceutical company, today announced that it will host an...